Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B
JAMA Intern Med
.
2019 May 1;179(5):640-641.
doi: 10.1001/jamainternmed.2018.8314.
Authors
Rena K Fox
1
,
Tamar H Taddei
2
3
,
David E Kaplan
4
5
Affiliations
1
Division of General Internal Medicine, School of Medicine, University of California, San Francisco.
2
Department of Medicine, Veterans Affairs Connecticut Healthcare System, West Haven.
3
Division of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut.
4
Division of Gastroenterology, School of Medicine, University of Pennsylvania Philadelphia.
5
Department of Medicine, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
PMID:
30882884
DOI:
10.1001/jamainternmed.2018.8314
No abstract available
Publication types
Comment
MeSH terms
Aspirin
Carcinoma, Hepatocellular*
Hepatitis B*
Hepatitis B, Chronic*
Humans
Liver Neoplasms*
Substances
Aspirin